Liver scan could free transplant patients from risky drugs
NCT ID NCT07206277
Summary
This study aims to see if a special ultrasound scan (FibroScan) can help doctors safely reduce the amount of strong anti-rejection drugs that liver transplant patients must take for life. These drugs prevent organ rejection but can cause serious long-term side effects like kidney problems, diabetes, and heart disease. Researchers will use the scan to select 50 stable patients who are at least 2 years post-transplant and try to lower their medication by 30%, monitoring them closely for safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOSUPPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alberta
RECRUITINGEdmonton, Alberta, T6G2R3, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.